id	sid	eid	entity	type
admet-2023	1	1	https://doi.org/10.5599/admet.2023 409 admet &	ORG
admet-2023	1	2	11(3	CARDINAL
admet-2023	1	3	2023	CARDINAL
admet-2023	1	4	409	CARDINAL
admet-2023	1	5	https://doi.org/10.5599/admet.2023	PERSON
admet-2023	1	6	issn	PERSON
admet-2023	1	7	1848-7718	DATE
admet-2023	1	8	kiyohiko sugano	PERSON
admet-2023	1	9	1	CARDINAL
admet-2023	1	10	noji-higashi	PERSON
admet-2023	1	11	kusatsu	PERSON
admet-2023	1	12	525-8577	CARDINAL
admet-2023	1	13	japan	GPE
admet-2023	2	1	561	CARDINAL
admet-2023	2	2	august 06	DATE
admet-2023	2	3	2023	CARDINAL
admet-2023	2	4	september 13	DATE
admet-2023	2	5	2023	CARDINAL
admet-2023	2	6	september 15	DATE
admet-2023	2	7	2023	CARDINAL
admet-2023	2	8	biopharmaceutics	ORG
admet-2023	6	1	qacs	ORG
admet-2023	8	1	77%	PERCENT
admet-2023	8	2	66%	PERCENT
admet-2023	8	3	79%	PERCENT
admet-2023	9	1	fed	ORG
admet-2023	9	2	3 and 15 mm	QUANTITY
admet-2023	9	3	fda	ORG
admet-2023	11	1	0.67	CARDINAL
admet-2023	11	2	0.47	CARDINAL
admet-2023	11	3	0.76	CARDINAL
admet-2023	12	1	0.39	CARDINAL
admet-2023	12	2	0.28	CARDINAL
admet-2023	12	3	0.59	CARDINAL
admet-2023	14	1	2023	CARDINAL
admet-2023	16	1	biopharmaceutics	ORG
admet-2023	16	2	1	CARDINAL
admet-2023	17	1	2	CARDINAL
admet-2023	18	1	9-11	CARDINAL
admet-2023	19	1	fed	ORG
admet-2023	19	2	12	CARDINAL
admet-2023	20	1	fed	ORG
admet-2023	23	1	13	CARDINAL
admet-2023	23	2	https://doi.org/10.5599/admet.2023 https://doi.org/10.5599/admet.2023	PERSON
admet-2023	23	3	t. sumiji	PERSON
admet-2023	23	4	k. sugano admet	ORG
admet-2023	23	5	11(3	CARDINAL
admet-2023	23	6	2023	CARDINAL
admet-2023	23	7	409	CARDINAL
admet-2023	24	1	14	CARDINAL
admet-2023	25	1	3	CARDINAL
admet-2023	26	1	bcs iii drugs	PERSON
admet-2023	26	2	fa	ORG
admet-2023	27	1	2,15	CARDINAL
admet-2023	28	1	3	CARDINAL
admet-2023	29	1	3	CARDINAL
admet-2023	30	1	fed	ORG
admet-2023	31	1	qacs	ORG
admet-2023	32	1	1,2	CARDINAL
admet-2023	32	2	length3	PERSON
admet-2023	32	3	1	CARDINAL
admet-2023	35	1	eff u epp	PERSON
admet-2023	35	2	2	CARDINAL
admet-2023	38	1	16	CARDINAL
admet-2023	39	1	fed	ORG
admet-2023	39	2	fu	NORP
admet-2023	39	3	fed	ORG
admet-2023	39	4	fu	NORP
admet-2023	39	5	fed	ORG
admet-2023	39	6	fa	ORG
admet-2023	39	7	0.7	CARDINAL
admet-2023	39	8	2	CARDINAL
admet-2023	40	1	qacs	ORG
admet-2023	41	1	trospium	PERSON
admet-2023	41	2	1	CARDINAL
admet-2023	42	1	1	CARDINAL
admet-2023	43	1	11(3	CARDINAL
admet-2023	43	2	2023	CARDINAL
admet-2023	43	3	409	CARDINAL
admet-2023	43	4	411	CARDINAL
admet-2023	44	1	100 mg ml-1	QUANTITY
admet-2023	45	1	3	CARDINAL
admet-2023	46	1	qacs	ORG
admet-2023	46	2	19	CARDINAL
admet-2023	46	3	20,21	CARDINAL
admet-2023	47	1	0.20	CARDINAL
admet-2023	47	2	0.15×10-6 cm	QUANTITY
admet-2023	47	3	3	CARDINAL
admet-2023	48	1	fa	ORG
admet-2023	48	2	about 13 %	PERCENT
admet-2023	48	3	6 %	PERCENT
admet-2023	49	1	22	CARDINAL
admet-2023	50	1	bcs iii	PERSON
admet-2023	51	1	77 %	PERCENT
admet-2023	51	2	66 %	PERCENT
admet-2023	51	3	79 %	PERCENT
admet-2023	52	1	25	CARDINAL
admet-2023	53	1	28-30	CARDINAL
admet-2023	57	1	tokyo	GPE
admet-2023	57	2	industry co., ltd (	ORG
admet-2023	57	3	tokyo	GPE
admet-2023	57	4	japan	GPE
admet-2023	58	1	sodium dihydrogen phosphate dihydrate	ORG
admet-2023	58	2	nah2po4 2h2o	PERSON
admet-2023	58	3	osaka	GPE
admet-2023	58	4	japan	GPE
admet-2023	59	1	funakoshi co., ltd (	ORG
admet-2023	59	2	tokyo	GPE
admet-2023	59	3	japan	GPE
admet-2023	60	1	toronto	GPE
admet-2023	60	2	ontario	GPE
admet-2023	60	3	canada	GPE
admet-2023	61	1	nof corporation	ORG
admet-2023	61	2	tokyo	GPE
admet-2023	61	3	japan	GPE
admet-2023	62	1	glyceryl mono-oleate	PERSON
admet-2023	62	2	gm	ORG
admet-2023	62	3	nippon surfactant industries co.	ORG
admet-2023	62	4	tokyo	GPE
admet-2023	62	5	japan	GPE
admet-2023	63	1	as-one	CARDINAL
admet-2023	63	2	osaka	GPE
admet-2023	63	3	japan	GPE
admet-2023	64	1	the food and drug adminstration	ORG
admet-2023	64	2	fda	ORG
admet-2023	64	3	itoham foods inc	ORG
admet-2023	64	4	japan	GPE
admet-2023	64	5	pasco shikishima corporation	ORG
admet-2023	64	6	japan	GPE
admet-2023	64	7	i.t.s farm co., ltd	ORG
admet-2023	64	8	japan	GPE
admet-2023	64	9	hoshino	NORP
admet-2023	64	10	heinz japan ltd	ORG
admet-2023	64	11	japan	GPE
admet-2023	64	12	oishii megumilk	PRODUCT
admet-2023	64	13	brand co., ltd	ORG
admet-2023	64	14	japan	GPE
admet-2023	64	15	megmilk snow brand co., ltd	ORG
admet-2023	64	16	japan	GPE
admet-2023	65	1	fda	ORG
admet-2023	65	2	fda	ORG
admet-2023	65	3	one	CARDINAL
admet-2023	65	4	half	CARDINAL
admet-2023	65	5	one	CARDINAL
admet-2023	65	6	55	CARDINAL
admet-2023	65	7	30	CARDINAL
admet-2023	65	8	100 ml	QUANTITY
admet-2023	66	1	fda	ORG
admet-2023	66	2	15 seconds	TIME
admet-2023	67	1	fda	ORG
admet-2023	68	1	sanplatec co., ltd	ORG
admet-2023	68	2	osaka	GPE
admet-2023	68	3	japan	GPE
admet-2023	68	4	3500	CARDINAL
admet-2023	70	1	1.5 ml	QUANTITY
admet-2023	71	1	fed	ORG
admet-2023	71	2	1	CARDINAL
admet-2023	72	1	31	CARDINAL
admet-2023	73	1	0.5 mm	QUANTITY
admet-2023	74	1	37 °	QUANTITY
admet-2023	74	2	1	CARDINAL
admet-2023	74	3	hplc (shimazu	ORG
admet-2023	74	4	lc-20 series	PERSON
admet-2023	74	5	zorbax	GPE
admet-2023	74	6	3.5 https://doi.org/10.5599/admet.2023	QUANTITY
admet-2023	74	7	k. sugano admet	ORG
admet-2023	74	8	11(3	CARDINAL
admet-2023	74	9	2023	CARDINAL
admet-2023	74	10	409	CARDINAL
admet-2023	74	11	0.6 ml	QUANTITY
admet-2023	74	12	0.1 %	PERCENT
admet-2023	74	13	25 %	PERCENT
admet-2023	74	14	35 %	PERCENT
admet-2023	74	15	20 %	PERCENT
admet-2023	74	16	10 %	PERCENT
admet-2023	74	17	260	CARDINAL
admet-2023	74	18	280	CARDINAL
admet-2023	74	19	265	CARDINAL
admet-2023	74	20	275	CARDINAL
admet-2023	74	21	40 °	CARDINAL
admet-2023	74	22	10	CARDINAL
admet-2023	75	1	1	CARDINAL
admet-2023	76	1	mm el	GPE
admet-2023	76	2	mm gm	PERSON
admet-2023	76	3	mm oa	PERSON
admet-2023	76	4	3 0.75	CARDINAL
admet-2023	76	5	7.5 1.88	CARDINAL
admet-2023	77	1	15 3.75	DATE
admet-2023	77	2	0 ×2fessif 30	PERCENT
admet-2023	77	3	15 3.75	CARDINAL
admet-2023	77	4	50	CARDINAL
admet-2023	77	5	28.6 mm	QUANTITY
admet-2023	77	6	106 mm	QUANTITY
admet-2023	77	7	6.5	CARDINAL
admet-2023	77	8	0.5 mm	QUANTITY
admet-2023	77	9	1	CARDINAL
admet-2023	77	10	0.25 mm	QUANTITY
admet-2023	79	1	2	CARDINAL
admet-2023	79	2	fu	NORP
admet-2023	80	1	1h	CARDINAL
admet-2023	80	2	fed	ORG
admet-2023	80	3	2	CARDINAL
admet-2023	81	1	qacs	ORG
admet-2023	81	2	44 to 74 %	PERCENT
admet-2023	82	1	un	ORG
admet-2023	83	1	16 %	PERCENT
admet-2023	84	1	2	CARDINAL
admet-2023	84	2	fda	ORG
admet-2023	84	3	fu	NORP
admet-2023	84	4	qacs	ORG
admet-2023	86	1	11(3	CARDINAL
admet-2023	86	2	2023	CARDINAL
admet-2023	86	3	409	CARDINAL
admet-2023	86	4	413	CARDINAL
admet-2023	86	5	2	CARDINAL
admet-2023	86	6	fu	NORP
admet-2023	86	7	1	CARDINAL
admet-2023	86	8	21.9 ± 0.1	QUANTITY
admet-2023	86	9	fassif	ORG
admet-2023	86	10	21.4	CARDINAL
admet-2023	86	11	21.1 ± 0.5 0.96 ±	MONEY
admet-2023	86	12	14.4 ± 0.6 0.66 ±	MONEY
admet-2023	86	13	13.0 ± 2.7 0.59 ± 0.15 0.61 ±	MONEY
admet-2023	86	14	12.2 ±	QUANTITY
admet-2023	87	1	8.3 ± 0.3 0.38 ± 0.02 0.39 ±	MONEY
admet-2023	87	2	0.02	CARDINAL
admet-2023	87	3	fassif	ORG
admet-2023	87	4	25.6 ± 0.2	MONEY
admet-2023	87	5	fassif	ORG
admet-2023	87	6	23.2	CARDINAL
admet-2023	88	1	16.8 ± 1.5 0.66 ±	MONEY
admet-2023	88	2	10.9 ± 0.2 0.42 ±	MONEY
admet-2023	88	3	6.1	CARDINAL
admet-2023	88	4	13.0 ±	MONEY
admet-2023	88	5	6.6 ± 0.6 0.26 ±	MONEY
admet-2023	88	6	fassif	ORG
admet-2023	88	7	17.5 ±	MONEY
admet-2023	89	1	1.0	CARDINAL
admet-2023	89	2	fassif	ORG
admet-2023	89	3	16.8	CARDINAL
admet-2023	89	4	16.3 ±	MONEY
admet-2023	89	5	12.8 ±	MONEY
admet-2023	89	6	8.7 ±	QUANTITY
admet-2023	89	7	fessif-v2	NORP
admet-2023	89	8	14.0	CARDINAL
admet-2023	90	1	9.8 ±	MONEY
admet-2023	90	2	fassif	ORG
admet-2023	90	3	40.1 ± 0.7	QUANTITY
admet-2023	90	4	36.4 ±	QUANTITY
admet-2023	91	1	33.9 ±	MONEY
admet-2023	91	2	± s.d.	GPE
admet-2023	91	3	3	CARDINAL
admet-2023	91	4	fu	NORP
admet-2023	91	5	fassif	ORG
admet-2023	91	6	fu	NORP
admet-2023	91	7	3	CARDINAL
admet-2023	92	1	fu	NORP
admet-2023	92	2	approximately 70 %	PERCENT
admet-2023	93	1	fed	ORG
admet-2023	93	2	at least one	CARDINAL
admet-2023	102	1	1	CARDINAL
admet-2023	106	1	25	CARDINAL
admet-2023	107	1	k. sugano admet	ORG
admet-2023	107	2	11(3	CARDINAL
admet-2023	107	3	2023	CARDINAL
admet-2023	107	4	409	CARDINAL
admet-2023	108	1	32	CARDINAL
admet-2023	110	1	33	CARDINAL
admet-2023	110	2	34	CARDINAL
admet-2023	111	1	25	CARDINAL
admet-2023	115	1	35	CARDINAL
admet-2023	117	1	fed	ORG
admet-2023	118	1	35	CARDINAL
admet-2023	118	2	60 min	QUANTITY
admet-2023	118	3	35	CARDINAL
admet-2023	119	1	3	CARDINAL
admet-2023	121	1	two	CARDINAL
admet-2023	121	2	25	CARDINAL
admet-2023	122	1	first	ORDINAL
admet-2023	127	1	2,3	CARDINAL
admet-2023	127	2	fu	NORP
admet-2023	127	3	fed	ORG
admet-2023	129	1	bcs ii	PERSON
admet-2023	129	2	fed	ORG
admet-2023	130	1	bcs ii	PERSON
admet-2023	133	1	fu	NORP
admet-2023	133	2	fed	ORG
admet-2023	133	3	sl-u	ORG
admet-2023	133	4	2	CARDINAL
admet-2023	135	1	2	CARDINAL
admet-2023	137	1	37	CARDINAL
admet-2023	139	1	fed	ORG
admet-2023	139	2	less than 20 %	PERCENT
admet-2023	145	1	3	CARDINAL
admet-2023	148	1	38,39	CARDINAL
admet-2023	149	1	11(3	CARDINAL
admet-2023	149	2	2023	CARDINAL
admet-2023	149	3	409	CARDINAL
admet-2023	149	4	https://doi.org/10.5599/admet.2023 415	PERSON
admet-2023	149	5	40	CARDINAL
admet-2023	151	1	fed	ORG
admet-2023	155	1	takeru sumiji	PERSON
admet-2023	156	1	kiyohiko sugano	PERSON
admet-2023	159	1	1	CARDINAL
admet-2023	159	2	k. sugano	PERSON
admet-2023	160	1	biopharmaceutics	ORG
admet-2023	162	1	john wiley & sons	ORG
admet-2023	162	2	hoboken	GPE
admet-2023	162	3	new jersey	GPE
admet-2023	162	4	usa	GPE
admet-2023	162	5	2012	DATE
admet-2023	164	1	2	CARDINAL
admet-2023	164	2	k. sugano	PERSON
admet-2023	164	3	m. kataoka	PERSON
admet-2023	164	4	mathews	ORG
admet-2023	164	5	s. yamashita	PERSON
admet-2023	166	1	european journal of pharmaceutical sciences	ORG
admet-2023	166	2	40	DATE
admet-2023	166	3	2010	DATE
admet-2023	166	4	118	CARDINAL
admet-2023	168	1	3	CARDINAL
admet-2023	168	2	s. ito	PERSON
admet-2023	168	3	t. fujita	PERSON
admet-2023	168	4	k. sugano	PERSON
admet-2023	170	1	european journal of pharmaceutical sciences	ORG
admet-2023	170	2	155	CARDINAL
admet-2023	170	3	2020) 105543	DATE
admet-2023	172	1	4	CARDINAL
admet-2023	174	1	24	CARDINAL
admet-2023	174	2	2022	CARDINAL
admet-2023	174	3	25	DATE
admet-2023	176	1	5	CARDINAL
admet-2023	176	2	f. kesisoglou	PERSON
admet-2023	178	1	60(suppl 1	DATE
admet-2023	178	2	2020	DATE
admet-2023	179	1	6	CARDINAL
admet-2023	180	1	pepin	PERSON
admet-2023	180	2	j.e. huckle	PERSON
admet-2023	180	3	r.v.	GPE
admet-2023	180	4	alluri	GPE
admet-2023	180	5	s. basu	PERSON
admet-2023	180	6	s. dodd	PERSON
admet-2023	180	7	n. parrott	PERSON
admet-2023	180	8	a.e.	GPE
admet-2023	182	1	23	CARDINAL
admet-2023	182	2	2021	CARDINAL
admet-2023	182	3	12	CARDINAL
admet-2023	184	1	7	CARDINAL
admet-2023	184	2	k. dement	PERSON
admet-2023	184	3	j. huckle	PERSON
admet-2023	184	4	p. bransford	PERSON
admet-2023	184	5	c. stillhart	GPE
admet-2023	184	6	r. lloyd	PERSON
admet-2023	184	7	r. alluri	PERSON
admet-2023	184	8	s. basu	PERSON
admet-2023	184	9	y. chen	PERSON
admet-2023	184	10	dhamankar	ORG
admet-2023	184	11	s. dodd	PERSON
admet-2023	184	12	p. kulkarni	PERSON
admet-2023	184	13	a. olivares-morales	PERSON
admet-2023	184	14	peng	PERSON
admet-2023	184	15	x. pepin	PERSON
admet-2023	184	16	x. ren	PERSON
admet-2023	184	17	t. tran	PERSON
admet-2023	184	18	c. tistaert	PERSON
admet-2023	184	19	t. heimbach	PERSON
admet-2023	184	20	f. kesisoglou	PERSON
admet-2023	184	21	c. wagner	PERSON
admet-2023	184	22	n. parrott	PERSON
admet-2023	186	1	22	CARDINAL
admet-2023	186	2	2020	DATE
admet-2023	186	3	123	CARDINAL
admet-2023	188	1	8	CARDINAL
admet-2023	188	2	s. castleberry.	PERSON
admet-2023	190	1	20	CARDINAL
admet-2023	190	2	2023	CARDINAL
admet-2023	192	1	9	CARDINAL
admet-2023	192	2	l. cheng	PERSON
admet-2023	192	3	h. wong	PERSON
admet-2023	194	1	12	CARDINAL
admet-2023	194	2	2020	DATE
admet-2023	194	3	672	CARDINAL
admet-2023	195	1	10	CARDINAL
admet-2023	195	2	m. li	PERSON
admet-2023	195	3	p. zhao	PERSON
admet-2023	195	4	y. pan	PERSON
admet-2023	195	5	c. wagner	PERSON
admet-2023	197	1	cpt	ORG
admet-2023	197	2	pharmacometrics & systems	ORG
admet-2023	197	3	7 (2018	PERCENT
admet-2023	197	4	82-89	DATE
admet-2023	199	1	https://doi.org/10.5599/admet.2023	PERSON
admet-2023	201	1	https://doi.org/10.3390/pharmaceutics12070672	GPE
admet-2023	201	2	k. sugano admet	ORG
admet-2023	201	3	11(3	CARDINAL
admet-2023	201	4	2023	CARDINAL
admet-2023	201	5	409	CARDINAL
admet-2023	202	1	11	CARDINAL
admet-2023	202	2	z. vinarov	PERSON
admet-2023	202	3	b. abrahamsson	PERSON
admet-2023	202	4	p. artursson	PERSON
admet-2023	202	5	h. batchelor	PERSON
admet-2023	202	6	a. bernkop-schnürch	PERSON
admet-2023	202	7	j. butler	PERSON
admet-2023	202	8	j. ceulemans	PERSON
admet-2023	202	9	n. davies	PERSON
admet-2023	202	10	d. dupont	PERSON
admet-2023	202	11	g.e.	GPE
admet-2023	202	12	b.t. griffin	PERSON
admet-2023	202	13	v. jannin	PERSON
admet-2023	202	14	j. keemink	PERSON
admet-2023	202	15	f. kesisoglou	PERSON
admet-2023	202	16	m. koziolek	PERSON
admet-2023	202	17	m. kuentz	PERSON
admet-2023	202	18	a. mackie	PERSON
admet-2023	202	19	a.j. meléndez-martínez	PERSON
admet-2023	202	20	m. mcallister	PERSON
admet-2023	202	21	a. müllertz	PERSON
admet-2023	202	22	c.m. o'driscoll	PERSON
admet-2023	202	23	n. parrott	PERSON
admet-2023	202	24	j. paszkowska	PERSON
admet-2023	202	25	c. reppas	PERSON
admet-2023	202	26	c. stillhart	PERSON
admet-2023	202	27	k. sugano	PERSON
admet-2023	202	28	e. toader	PERSON
admet-2023	202	29	k. valentová	PERSON
admet-2023	202	30	m. vertzoni	PERSON
admet-2023	202	31	c.g. wilson	PERSON
admet-2023	202	32	p. augustijns	PERSON
admet-2023	204	1	171	CARDINAL
admet-2023	204	2	2021	CARDINAL
admet-2023	204	3	289	CARDINAL
admet-2023	206	1	12	CARDINAL
admet-2023	208	1	48	CARDINAL
admet-2023	208	2	2023) 100488	DATE
admet-2023	210	1	13	CARDINAL
admet-2023	210	2	g.l. amidon	PERSON
admet-2023	210	3	j.e. polli	PERSON
admet-2023	210	4	h. zhao	PERSON
admet-2023	210	5	m.u. mehta	PERSON
admet-2023	210	6	d.p. conner	PERSON
admet-2023	210	7	v.p. shah	PERSON
admet-2023	210	8	l.j. lesko	PERSON
admet-2023	210	9	m.l. chen	PERSON
admet-2023	210	10	v.h. lee	PERSON
admet-2023	210	11	hussain	PERSON
admet-2023	211	1	biopharmaceutics	ORG
admet-2023	212	1	19	CARDINAL
admet-2023	212	2	2002	DATE
admet-2023	212	3	921	CARDINAL
admet-2023	214	1	14	CARDINAL
admet-2023	214	2	singh	GPE
admet-2023	216	1	65	CARDINAL
admet-2023	216	2	55	CARDINAL
admet-2023	218	1	15	CARDINAL
admet-2023	218	2	k. sugano	PERSON
admet-2023	218	3	k. terada	PERSON
admet-2023	220	1	104	CARDINAL
admet-2023	220	2	2015	CARDINAL
admet-2023	220	3	2777-2788	CARDINAL
admet-2023	222	1	16	CARDINAL
admet-2023	222	2	h. lennernäs	PERSON
admet-2023	222	3	c.g.	GPE
admet-2023	224	1	10	CARDINAL
admet-2023	224	2	1993	DATE
admet-2023	224	3	879	CARDINAL
admet-2023	226	1	17	CARDINAL
admet-2023	226	2	t. yamaguchi	GPE
admet-2023	226	3	c. ikeda	PERSON
admet-2023	229	1	tokyo	GPE
admet-2023	229	2	34	CARDINAL
admet-2023	229	3	1986	DATE
admet-2023	229	4	3836	CARDINAL
admet-2023	231	1	18	CARDINAL
admet-2023	231	2	b. beck	PERSON
admet-2023	231	3	m. oth	PERSON
admet-2023	231	4	p. augustijns	PERSON
admet-2023	233	1	international journal of pharmaceutics 274 (	ORG
admet-2023	233	2	2004	DATE
admet-2023	233	3	221	CARDINAL
admet-2023	234	1	19	CARDINAL
admet-2023	234	2	g. bouchard	PERSON
admet-2023	234	3	p.a.	GPE
admet-2023	234	4	b. testa	PERSON
admet-2023	234	5	v. gobry	PERSON
admet-2023	234	6	girault	PERSON
admet-2023	235	1	galvani	PERSON
admet-2023	236	1	18	CARDINAL
admet-2023	236	2	702	CARDINAL
admet-2023	238	1	20	CARDINAL
admet-2023	238	2	k. sugano	PERSON
admet-2023	238	3	m. machida	PERSON
admet-2023	238	4	y. asoh	ORG
admet-2023	240	1	international journal of pharmaceutics	ORG
admet-2023	240	2	275	CARDINAL
admet-2023	240	3	2004	DATE
admet-2023	240	4	271	CARDINAL
admet-2023	242	1	21	CARDINAL
admet-2023	242	2	h. fischer	PERSON
admet-2023	242	3	m. kansy	PERSON
admet-2023	242	4	a. avdeef	PERSON
admet-2023	242	5	f. senner	PERSON
admet-2023	244	1	european journal of pharmaceutical sciences	ORG
admet-2023	244	2	31	DATE
admet-2023	244	3	2007	DATE
admet-2023	244	4	32	CARDINAL
admet-2023	246	1	22	CARDINAL
admet-2023	246	2	a. kubis	PERSON
admet-2023	246	3	g. krumbiegel	PERSON
admet-2023	246	4	w. lang	PERSON
admet-2023	246	5	h.p. merkle	PERSON
admet-2023	246	6	w. wächter	PERSON
admet-2023	246	7	h. spahn-langguth	PERSON
admet-2023	246	8	r. weyhenmeyer	PERSON
admet-2023	248	1	european journal of pharmaceutics	ORG
admet-2023	248	2	biopharmaceutics	ORG
admet-2023	248	3	43 (1997	DATE
admet-2023	248	4	265	CARDINAL
admet-2023	249	1	23	CARDINAL
admet-2023	249	2	a. jetter	PERSON
admet-2023	249	3	k.p.	PERSON
admet-2023	251	1	44 (2005	DATE
admet-2023	251	2	701	CARDINAL
admet-2023	253	1	24	CARDINAL
admet-2023	253	2	vose	GPE
admet-2023	253	3	ford	ORG
admet-2023	253	4	s.j. grigson	PERSON
admet-2023	253	5	n.j	GPE
admet-2023	253	6	haskins	GPE
admet-2023	253	7	m. prout	PERSON
admet-2023	253	8	stevens	PERSON
admet-2023	253	9	d.a.	PERSON
admet-2023	253	10	r.f. palmer	ORG
admet-2023	253	11	h. rudel	PERSON
admet-2023	255	1	british	NORP
admet-2023	255	2	7 (1979	DATE
admet-2023	255	3	89	CARDINAL
admet-2023	257	1	25	CARDINAL
admet-2023	257	2	m. weiss	PERSON
admet-2023	257	3	c. modess	PERSON
admet-2023	257	4	d. wegner	PERSON
admet-2023	257	5	t. roustom	GPE
admet-2023	257	6	c. neumeister	PERSON
admet-2023	257	7	h.u. schulz	GPE
admet-2023	257	8	w. weitschies	PERSON
admet-2023	257	9	w. siegmund	PERSON
admet-2023	258	1	two	CARDINAL
admet-2023	258	2	11(3	CARDINAL
admet-2023	258	3	2023	CARDINAL
admet-2023	258	4	409	CARDINAL
admet-2023	258	5	https://doi.org/10.5599/admet.2023 417	PERSON
admet-2023	259	1	515	CARDINAL
admet-2023	259	2	2016	CARDINAL
admet-2023	259	3	367	CARDINAL
admet-2023	261	1	26	CARDINAL
admet-2023	261	2	b.g. charles	PERSON
admet-2023	261	3	p.j. ravenscroft	GPE
admet-2023	261	4	whyte	PERSON
admet-2023	261	5	16	CARDINAL
admet-2023	261	6	758759	DATE
admet-2023	262	1	https://doi.org/10.1111/j.1365-2125.1983.tb02261.x	NORP
admet-2023	263	1	27	CARDINAL
admet-2023	263	2	k. ohtsubo	PERSON
admet-2023	263	3	n. fujii	PERSON
admet-2023	263	4	s. higuchi	GPE
admet-2023	263	5	t. aoyama	ORG
admet-2023	263	6	i. goto	PERSON
admet-2023	265	1	european journal	ORG
admet-2023	265	2	42	CARDINAL
admet-2023	265	3	1992	DATE
admet-2023	265	4	371	CARDINAL
admet-2023	267	1	28	CARDINAL
admet-2023	267	2	s. modi	GPE
admet-2023	267	3	anderson	PERSON
admet-2023	269	1	10 (2013	DATE
admet-2023	271	1	29	CARDINAL
admet-2023	271	2	y. lu	PERSON
admet-2023	271	3	j. qi	PERSON
admet-2023	271	4	m. niu	PERSON
admet-2023	271	5	r. lian	PERSON
admet-2023	271	6	f. hu	PERSON
admet-2023	271	7	w. wu	PERSON
admet-2023	273	1	6 (2011	DATE
admet-2023	273	2	965	CARDINAL
admet-2023	275	1	30	CARDINAL
admet-2023	275	2	k. yano	PERSON
admet-2023	275	3	m. kataoka	PERSON
admet-2023	275	4	s. sakuma	PERSON
admet-2023	275	5	s. yamashita	PERSON
admet-2023	277	1	99	CARDINAL
admet-2023	277	2	2010	DATE
admet-2023	277	3	1336-1345	DATE
admet-2023	278	1	https://doi.org/10.1002/jps.21919	LOC
admet-2023	279	1	31	CARDINAL
admet-2023	279	2	silva	PERSON
admet-2023	279	3	n.m. davies	PERSON
admet-2023	279	4	n. bou-chacra	PERSON
admet-2023	279	5	r. löbenberg	PERSON
admet-2023	281	1	29	CARDINAL
admet-2023	281	2	2022	CARDINAL
admet-2023	281	3	62	CARDINAL
admet-2023	283	1	32	CARDINAL
admet-2023	283	2	a. radwan	PERSON
admet-2023	283	3	g.l. amidon	PERSON
admet-2023	285	1	biopharmaceutics & drug	ORG
admet-2023	285	2	33	DATE
admet-2023	285	3	2012	DATE
admet-2023	285	4	403	CARDINAL
admet-2023	287	1	33	CARDINAL
admet-2023	287	2	s. schröder	PERSON
admet-2023	287	3	a. jetter	PERSON
admet-2023	287	4	m. zaigler	PERSON
admet-2023	287	5	r. weyhenmeyer	PERSON
admet-2023	287	6	g. krumbiegel	PERSON
admet-2023	287	7	w. wächter	PERSON
admet-2023	289	1	internatinal journal of clinical pharmacology	ORG
admet-2023	289	2	42	DATE
admet-2023	289	3	543	CARDINAL
admet-2023	290	1	34	CARDINAL
admet-2023	290	2	s. cvijić	PERSON
admet-2023	291	1	fed	ORG
admet-2023	292	1	biopharmaceutics & drug	ORG
admet-2023	292	2	35	CARDINAL
admet-2023	292	3	2014	DATE
admet-2023	292	4	553	CARDINAL
admet-2023	294	1	35	CARDINAL
admet-2023	294	2	s. reuss	PERSON
admet-2023	294	3	g.l. amidon	GPE
admet-2023	296	1	10 (2013	DATE
admet-2023	296	2	3989-3996	CARDINAL
admet-2023	298	1	36	CARDINAL
admet-2023	298	2	j.k. takemoto	PERSON
admet-2023	298	3	d.r. brocks	PERSON
admet-2023	298	4	j.a.	PERSON
admet-2023	298	5	yáñez	ORG
admet-2023	300	1	49	DATE
admet-2023	300	2	2010	DATE
admet-2023	300	3	351	CARDINAL
admet-2023	302	1	37	CARDINAL
admet-2023	302	2	k. sugano	PERSON
admet-2023	304	1	9	CARDINAL
admet-2023	304	2	2021	CARDINAL
admet-2023	304	3	75	CARDINAL
admet-2023	305	1	38	CARDINAL
admet-2023	305	2	m. kansy	PERSON
admet-2023	305	3	f. senner	PERSON
admet-2023	305	4	k. gubernator	PERSON
admet-2023	307	1	journal of medicinal chemistry	ORG
admet-2023	307	2	41	CARDINAL
admet-2023	307	3	1998	DATE
admet-2023	307	4	1007-1010	DATE
admet-2023	309	1	39	CARDINAL
admet-2023	309	2	a. avdeef	PERSON
admet-2023	309	3	s. bendels	PERSON
admet-2023	309	4	l. di	PERSON
admet-2023	309	5	m. kansy	PERSON
admet-2023	309	6	k. sugano	PERSON
admet-2023	309	7	y. yamauchi	ORG
admet-2023	310	1	pampa	ORG
admet-2023	311	1	96	DATE
admet-2023	311	2	2007	DATE
admet-2023	311	3	2893-2909	DATE
admet-2023	313	1	40	CARDINAL
admet-2023	313	2	k. sugano	PERSON
admet-2023	313	3	n. takata	PERSON
admet-2023	313	4	m. machida	PERSON
admet-2023	313	5	k. saitoh	PERSON
admet-2023	313	6	k. terada	PERSON
admet-2023	315	1	international journal of pharmaceutics	ORG
admet-2023	315	2	24 (2002	DATE
admet-2023	315	3	241	CARDINAL
admet-2023	317	1	2023	CARDINAL
admet-2023	317	2	iapc	ORG
admet-2023	317	3	zagreb	GPE
admet-2023	317	4	croatia	GPE
admet-2023	318	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-2023	318	2	https://doi.org/10.5599/admet.2023	PERSON
admet-2023	320	1	http://creativecommons.org/licenses/by/3.0/	ORG